Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04913155 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

HANSE - Holistic Implementation Study Assessing a Northern German Interdisciplinary Lung Cancer Screening Effort

Study acronym: HANSE
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Jun 2026 to Mar 1, 2024
    • Start date: May 26, 2021 to May 20, 2021
    • Site details revised at 3 of 3 sites
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Enrollment target: 5500 to 12100
    • Start date changed from estimate of Jun 2021 to May 26, 2021
    • Site details revised at 3 of 3 sites
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The HANSE study is primarily intended as a pilot to provide evidence that a holistic and effective lung cancer screening program can be implemented in Germany and that such a screening program can be integrated in the current infrastructure of certified lung cancer centers.
Trial Details
NCT Number NCT04913155
Lead Sponsor Hannover Medical School
Collaborators: LungenClinic Grosshansdorf, University Hospital Schleswig-Holstein, German Center for Lung Research
Conditions
(from sponsor)		 Lung Cancer
Related terms Lung Neoplasms
Enrollment 12,100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov